Pharmabiz25m
US FDA approves Allergan’s Botox Cosmetic for moderate to severe vertical bands connecting the jaw and neck
Irvine, California Monday, October 21, 2024, 09:00 Hrs [IST] ...
Pharmabiz1h
DTAB agrees with proposal to amend ND&CT Rules to ease registration process of Ethics Committees
Gireesh Babu, New Delhi Monday, October 21, 2024, 08:00 Hrs [IST] ...
Pharmabiz1h
Pondicherry DC dept conducts segment-wise training programme on Revised Schedule M for pharma SMEs
Peethaambaran Kunnathoor, Chennai Monday, October 21, 2024, 08:00 Hrs [IST] ...
Pharmabiz1h
DGFT introduces e-submission system for Appendix 4H certificates to streamline pharma export processes
DGFT introduces e-submission system for Appendix 4H certificates to streamline pharma export processes: Shardul Nautiyal, Mumbai Monday, October 21, 2024, 08:00 Hrs [IST] In a sig ...
Pharmabiz1h
Pharma exports report 8% growth during first six months of current fiscal year
Pharma exports report 8% growth during first six months of current fiscal year: Gireesh Babu, New Delhi Monday, October 21, 2024, 08:00 Hrs [IST] Exports of drugs and pharmaceutic ...
Pharmabiz1h
DGTR initiates anti-dumping investigation on MEG imports from Kuwait, Saudi Arabia & Singapore
DGTR initiates anti-dumping investigation on MEG imports from Kuwait, Saudi Arabia & Singapore: Shardul Nautiyal, Mumbai Monday, October 21, 2024, 08:00 Hrs [IST] The Directorate ...
Pharmabiz1d
Gland Pharma appoints Shyamakant Giri as new CEO
Gland Pharma’s board has approved the appointment of Shyamakant Giri as the new chief executive officer (CEO) of the company.
Pharmabiz1d
Clarametyx reports progress on study of antibody therapy CMTX-101 for infections associated with CF, to begin phase 2a portion of the trial
Clarametyx reports progress on study of antibody therapy CMTX-101 for infections associated with CF, to begin phase 2a portion of the trial: Columbus, Ohio Saturday, October 19, 2 ...
Pharmabiz1d
AbbVie’s Vyalev receives US FDA approval to treat adults living with advanced Parkinson's disease
AbbVie announced that the US Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for the ...
Pharmabiz1d
Eterna Therapeutics collaborates with Factor Bioscience to speed up cell therapy development for oncology, autoimmune & rare diseases
Eterna Therapeutics collaborates with Factor Bioscience to speed up cell therapy development for oncology, autoimmune & rare diseases: Cambridge, Massachusetts Saturday, October 1 ...
Pharmabiz1d
Kane Biotech inks agreement with XSONX to distribute wound hygiene system in Canada, Australia, New Zealand & GCC countries
Kane Biotech inks agreement with XSONX to distribute wound hygiene system in Canada, Australia, New Zealand & GCC countries: Winnipeg, Manitoba Saturday, October 19, 2024, 16:00 H ...
Pharmabiz1d
TuHURA Biosciences announces completion of merger transaction with Kintara Therapeutics
TuHURA Biosciences announces completion of merger transaction with Kintara Therapeutics: Tampa, Florida Saturday, October 19, 2024, 15:00 Hrs [IST] TuHURA Biosciences, a phase 3 r ...